EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Investigating disparities in smoking cessation treatment for veterans with multiple sclerosis: A national analysis

Carri S Polick iD, Paul Dennis, Patrick S Calhoun, Tiffany J Braley, Eunice Lee, Sarah Wilson

Brain and Behavior · 2024

DOI: 10.1002/brb3.3513 ↗

At a glance

Journal article in Brain and Behavior, 2024. Written by Carri S Polick and 5 co-authors. Institution: Durham VA Health Care System, Durham, North Carolina, USA. Major MEDLINE topics: Veterans, Smoking Cessation, Multiple Sclerosis, Tobacco Use Cessation Devices. Cited 3 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY 4.0). Funded by: HSRD VA, U.S. Department of Veterans Affairs.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background and aims Smoking is a risk factor for multiple sclerosis (MS) development, symptom burden, decreased medication efficacy, and increased disease‐related mortality. Veterans with MS (VwMS) smoke at critically high rates; however, treatment rates and possible disparities are unknown. To promote equitable treatment, we aim to investigate smoking cessation prescription practices for VwMS across social determinant factors.

Methods

We extracted data from the national Veterans Health Administration electronic health records between October 1, 2017, and September 30, 2018. To derive marginal estimates of the association of MS with receipt of smoking‐cessation pharmacotherapy, we used propensity score matching through the extreme gradient boosting machine learning model. VwMS who smoke were matched with veterans without MS who smoke on factors including age, race, depression, and healthcare visits. To assess the marginal association of MS with different cessation treatments, we used logistic regression and conducted stratified analyses by sex, race, and ethnicity.

Results

The matched sample achieved a good balance across most covariates, compared to the pre‐match sample. VwMS ( n = 3320) had decreased odds of receiving prescriptions for nicotine patches ([Odds Ratio] OR = 0.86, p < .01), non‐patch nicotine replacement therapy (NRT; OR = 0.81, p < .001), and standard practice dual NRT ( OR = 0.77, p < .01), compared to matches without MS ( n = 13,280). Men with MS had lower odds of receiving prescriptions for nicotine patches ( OR = 0.88, p = .05), non‐patch NRT ( OR = 0.77, p < .001), and dual NRT ( OR = 0.72, p < .001). Similarly, Black VwMS had lower odds of receiving prescriptions for patches ( OR = 0.62, p < .001), non‐patch NRT ( OR = 0.75, p < .05), and dual NRT ( OR = 0.52, p < .01). The odds of receiving prescriptions for bupropion or varenicline did not differ between VwMS and matches without MS.

Conclusion

VwMS received significantly less smoking cessation treatment, compared to matched controls without MS, showing a critical gap in health services as VwMS are not receiving dual NRT as the standard of care. Prescription rates were especially lower for male and Black VwMS, suggesting that under‐represented demographic groups outside of the white female category, most often considered as the “traditional MS” group, could be under‐treated regarding smoking cessation support. This foundational work will help inform future work to promote equitable treatment and implementation of cessation interventions for people living with MS.

Subjects

MeSH terms (MEDLINE)

VeteransSmoking CessationMultiple SclerosisTobacco Use Cessation DevicesHealthcare DisparitiesHumansMaleFemaleMiddle AgedUnited StatesAdultUnited States Department of Veterans AffairsSmoking Cessation AgentsAgedBupropionVarenicline

Author keywords

Health equityMultiple SclerosisSmoking cessationVeterans

Substances

Smoking Cessation AgentsBupropionVarenicline

Authors and institutions

  • Durham VA Health Care System, Durham, North Carolina, USA.
  • School of Nursing, Duke University, Durham, North Carolina, USA.
  • Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina, USA.
  • Department of Neurology, Michigan Medicine, Ann Arbor, Michigan, USA.
  • Duke University, Durham, North Carolina, USA.

ORCID profiles: Carri S Polick

Funding

  • HSRD VA
  • U.S. Department of Veterans Affairs

Cite

APA

Polick, C. S., Dennis, P., Calhoun, P. S., Braley, T. J., Lee, E., & Wilson, S. (2024). Investigating disparities in smoking cessation treatment for veterans with multiple sclerosis: A national analysis. Brain and Behavior. https://doi.org/10.1002/brb3.3513

Vancouver

Polick CS, Dennis P, Calhoun PS, Braley TJ, Lee E, Wilson S. Investigating disparities in smoking cessation treatment for veterans with multiple sclerosis: A national analysis. Brain and Behavior. 2024. doi:10.1002/brb3.3513

BibTeX
@article{Polick2024,
  author = {Polick, Carri S and Dennis, Paul and Calhoun, Patrick S and Braley, Tiffany J and Lee, Eunice and Wilson, Sarah},
  title = {Investigating disparities in smoking cessation treatment for veterans with multiple sclerosis: A national analysis},
  journal = {Brain and Behavior},
  year = {2024},
  doi = {10.1002/brb3.3513}
}
Start for free →